Twitter LinkedIn
    Saturday, February 4
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»Mergers & Acquisitions»Big pharma and private equity seek healthy returns in Europe’s east
    Mergers & Acquisitions

    Big pharma and private equity seek healthy returns in Europe’s east

    May 21, 20211 Min Read
    LinkedIn Facebook Twitter Email WhatsApp
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    In the race to supply vaccines to end the COVID-19 pandemic, U.S. drug developer Novavax turned to emerging Europe to speed up production with a pair of deals that endorsed a growing trend for consolidation in the region.

    As part of a doubling in merger activity, buoyed by a combination of private equity and big pharma, Novavax (NVAX.O) bought the Praha Vaccines factory near Prague in a $167 million transaction last May. It followed up by partnering with Polish biotech company Mabion (MABP.WA) in March

    For private equity, there is the lure of high returns, while big pharma can reduce costs by buying growing firms that have carried out large amounts of research and the location in the European Union means widely recognised standards are met.

    The total value of inbound deals with disclosed value in the healthcare and pharmaceuticals industry in central and eastern Europe doubled to 1.9 billion euros ($2.31 billion) in 2020 from 932 million euros a year earlier, a report from consultancy Merger market and Mazars found.

    Read more/Source: Reuters

    BY: Michael Kahn, AnnaKoper, Agnieszka Barteczko

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    Mergers & Acquisitions peinsider Private Equity
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    Euroclear moves into $9.8 trillion private asset market with Goji buy

    December 21, 2022

    CAI raises over $1B for inaugural fund and co-investment programme

    November 18, 2022

    KKR looking to sell Canadian gas producer Westbrick for $1.13B

    November 18, 2022

    Carlyle targeting $1.6B for second renewables fund

    November 18, 2022

    Comments are closed.

    Other Articles

    Investment firm Coller Capital explores sale

    December 14, 2021

    Francisco Partners acquires Kobalt

    September 8, 2022

    Union vote clears way for private equity investment in New Zealand Rugby

    June 2, 2022

    Eurazeo launches Sustainable Maritime Intrastructure Thematic Fund

    April 23, 2021

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2023 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.


    Lost password?